More info on the EACTS annual edition
Learn MoreWhere to find us at EACTS Booth
See Our location
Time
|
Session Details
|
 Room
|
|||
|---|---|---|---|---|---|
| 11:00 – 13:00 | Aortic Valve | Hall D | Add to Calendar | ||
|
Endoscopic sutureless aortic valve replacement (Live 3D)
-M.Solinas (Italy) Minimally-invasive aortic annulus enlargement and valve replacement (live 3D) - L. Conradi (Germany) |
|||||
| 13:30 – 15:15 | Aorta and Coronary | Hall D | Add to Calendar | ||
| 15:40 – 18:00 | Atrioventricular Valves | Hall D | Add to Calendar | ||
|
Endoscopic mitral valve replacement using a new prosthesis and automatic suturing device (Live 3D)
- A. Pitsis (Greece) |
|
Time
|
Session Details
|
Room
|
|||
|---|---|---|---|---|---|
| 08:30 – 09:30 | President's Choice | Hall D | Add to Calendar | ||
|
Statin treatment after surgical aortic valve replacement due to aortic stenosis is associated with better long-term outcome
– E. Pan (USA) More information Extracted from the 2023 EACTS program, focusing on heart valve disease and devices. All abstracts have been extracted from the EACTS website |
|||||
| 10:00 – 11:00 | Fixing tricuspid regurgitation:work in progress! | Hall G1 | Add to Calendar | ||
|
Risk assessment in tricuspid surgery: the TRISCORE- J.Dreyfus
Skilful omission of ring annuloplasty: you can dare in pulmonary thromboendarterectomy – M. Castella (Spain) Techniques for Tricuspid Valve Repair: do subannular approaches really help G. Färber- (Germany) |
|||||
| 11:15 – 12:00 | Honoured Guest | Hall D | Add to Calendar | ||
| 13:45 – 14:45 | Supporting the economics of patient management and procedures in cardiac surgery through science | 0.31/0.32 | Add to Calendar | ||
|
Improving the quality of care and efficiency in cardiac surgery through an early discharge algorithm– E. Zias (USA)
|
|||||
| 13:45 – 14:45 | Artificial intelligence in procedural planning and performance in transcatheter techniques | Hall G1 | Add to Calendar | ||
|
Can AI speed up and evaluate echo data in transcatheter procedures-G. Strange (Australia)
|
|||||
| 13:45 – 14:45 | Improving CABG outcome in women: a call to action | Hall E2(Interactive) | Add to Calendar | ||
|
The need for surgical trials in women; the case for ROMA: Women- M. Gaudino (USA)
|
|||||
| 13:45 – 14:45 | Update on tissue valve durability | Hall D | Add to Calendar | ||
|
Experimental evidence to increase prosthetic valve durability - P. Akhyari
What do real world data show us ? Insights from the Indure Registry- Lauger Is improved haemodynamic a way to prolong durability?- R. Sádaba (Pamplona, Spain) Is long term durability maintained when using sutureless valves– B. Meuris |
|||||
| 15:00 – 16:00 | Mitral valve interventions, challenges in 2023 | Hall K2 | Add to Calendar | ||
| 17:30 – 18:30 | Late Breaking Science 3 | Hall E2(Interactive) | Add to Calendar | ||
|
Five-year Clinical and Echocardiographic Results of New Generation Bioprosthetic valves: Real World data from a multicenter registry – A.Francica (Italy)
Gender-based analysis of patient outcomes and safety of surgical aortic valve replacement – A.Zierer (Austria) Subannular Repair for Secondary Mitral Regurgitation with restricted systolic leaflet Motion (type IIIb): 2-year results from REFORM-MR registry– E. Girdauskas (Germany) |
|
Time
|
Session Details
|
Room
|
|||
|---|---|---|---|---|---|
| 08:30 – 09:30 | Science behind aortic valve repair | Hall G2 | Add to Calendar | ||
|
Outcome differences depending on bicuspid valve phenotype
- L. de Kerchove (Belgium)
|
|||||
| 10:00 – 11:00 | Aortic Valve repair | Hall G1 | Add to Calendar | ||
|
Yacoub versus Bentall procedure in a nationwide propensity-matched long-term comparison- J. Gofus
More information Twenty-five Years Experience of Isolated BAV Repair - T. Ehrlich More information Extracted from the 2023 EACTS program, focusing on heart valve disease and devices. All abstracts have been extracted from the EACTS website |
|||||
| 11:15 – 12:00 | Presidential Address | Hall D | Add to Calendar | ||
|
The Death of Dogma is the Birth of Reality (Immanuel Kant)- P. Perier
|
|||||
| 16:15 – 17:15 | Unsolved issues in transcatheter valve procedures | Hall E1 | Add to Calendar | ||
|
Five-year outcomes after transcatheter versus surgical aortic valve replacement in low-risk patients- V. Lodo (Italy)
More information Gender differences in transcatheter aortic valve implantation- V. Lodo More information Extracted from the 2023 EACTS program, focusing on heart valve disease and devices. All abstracts have been extracted from the EACTS website |
|||||
| 16:15 – 17:15 | AV replacement | Hall F1 (Interactive) | Add to Calendar | ||
|
Mechanical or biological aortic valve replacement in hemodialysis patients:
a propensity score matching analysis with long-term results from the TriNetX global network- B. Del Forno More information Sutureless prostheses inside degenerated stentless aortic valves and bioroots – clinical outcomes from a multi-centre experience- M. Silaschi (Germany) More information Structural valve degeneration after ten-years from aortic valve replacement with pericardial prosthesis in non-elderly adults - A. Francica More information Impact of explanted valve type on outcomes in re-operative aortic valve replacements - P. Narayan More information Extracted from the 2023 EACTS program, focusing on heart valve disease and devices. All abstracts have been extracted from the EACTS website |
|
Time
|
Session Details
|
Room
|
|||
|---|---|---|---|---|---|
| 08:00 – 09:00 | Aortic Valve replacement | Hall K2 | Add to Calendar | ||
|
5-year results from a prospective, single-arm European trial on decellularized allografts for aortic valve replacement-The ARISE Study - S. Sarikouch
More information Long-Term Outcomes of the Ross Procedure Versus Bioprosthetic Versus Mechanical Aortic Valve Replacement: A Network Meta-Analysis - J. Velasco More information Hemodynamic Function of Contemporary Surgical Aortic Valves 1 Year Postimplant- R. Klautz More information Extracted from the 2023 EACTS program, focusing on heart valve disease and devices. All abstracts have been extracted from the EACTS website |
|||||
| 10:30– 12:00 | Trial Update | Hall D | Add to Calendar |
|
Time
|
Session Details
|
Room
|
||
|---|---|---|---|---|
| 08:30 – 10:00 | New options for imaging in planning and performance of transcatheter treatment, including remote proctoring | Amber 1 & 2 | ||
| 10:30 – 12:00 | Clinical trial updates | Auditorium |
Endoscopic sutureless aortic valve replacement (Live 3D) , M. Solinas (Italy)
Minimally-invasive aortic annulus enlargement and valve replacement (Live 3D) – L. Conradi (Germany)
Endoscopic mitral valve replacement using a new prosthesis and automatic suturing device (Live 3D) – A. Pitsis (Greece)
Statin treatment after surgical aortic valve replacement due to aortic stenosis is associated with better long-term outcome – E. Pan (USA)
More informationExtracted from the 2023 EACTS program, focusing on heart valve disease and devices.
All abstracts have been extracted from the EACTS website
Risk assessment in tricuspid surgery: the TRISCORE – J. Dreyfus (France)
Skilful omission of ring annuloplasty: you can dare in pulmonary thromboendarterectomy – M. Castella (Spain)
Techniques for Tricuspid Valve Repair: do subannular approaches really help – G. Färber- (Germany)
Improving the quality of care and efficiency in cardiac surgery through an early discharge algorithm – E. Zias (USA)
Can AI speed up and evaluate echo data in transcatheter procedures - G. Strange (Australia)
The need for surgical trials in women; the case for ROMA: Women - M. Gaudino (USA)
Experimental evidence to increase prosthetic valve durability – P. Akhyari
What do real world data show us ? Insights from the Indure Registry - Lauger
Is improved haemodynamic a way to prolong durability? - R. Sádaba (Pamplona, Spain)
Is long term durability maintained when using sutureless valves – B. Meuris
Five-year Clinical and Echocardiographic Results of New Generation Bioprosthetic valves: Real World data from a multicenter registry – A.Francica (Italy)
Gender-based analysis of patient outcomes and safety of surgical aortic valve replacement – A.Zierer (Austria)
Subannular Repair for Secondary Mitral Regurgitation with restricted systolic leaflet Motion (type IIIb): 2-year results from REFORM-MR registry – E. Girdauskas (Germany)
Outcome differences depending on bicuspid valve phenotype - L. de Kerchove (Belgium)
Yacoub versus Bentall procedure in a nationwide propensity-matched long-term comparison - J. Gofus
More informationTwenty-five Years Experience of Isolated BAV Repair - T. Ehrlich
More informationExtracted from the 2023 EACTS program, focusing on heart valve disease and devices.
All abstracts have been extracted from the EACTS website
The Death of Dogma is the Birth of Reality (Immanuel Kant) - P. Perier
Five-year outcomes after transcatheter versus surgical aortic valve replacement in low-risk patients - V. Lodo (Italy)
More informationGender differences in transcatheter aortic valve implantation - V. Lodo
More informationExtracted from the 2023 EACTS program, focusing on heart valve disease and devices.
All abstracts have been extracted from the EACTS website
Mechanical or biological aortic valve replacement in hemodialysis patients: a propensity score matching analysis with long-term results from the TriNetX global network - B. Del Forno
More informationSutureless prostheses inside degenerated stentless aortic valves and bioroots – clinical outcomes from a multi-centre experience - M. Silaschi (Germany)
More informationStructural valve degeneration after ten-years from aortic valve replacement with pericardial prosthesis in non-elderly adults - A. Francica
More informationImpact of explanted valve type on outcomes in re-operative aortic valve replacements - P. Narayan
More informationExtracted from the 2023 EACTS program, focusing on heart valve disease and devices.
All abstracts have been extracted from the EACTS website
5-year results from a prospective, single-arm European trial on decellularized allografts for aortic valve replacement -The ARISE Study - S. Sarikouch
More informationLong-Term Outcomes of the Ross Procedure Versus Bioprosthetic Versus Mechanical Aortic Valve Replacement: A Network Meta-Analysis - J. Velasco
More informationHemodynamic Function of Contemporary Surgical Aortic Valves 1 Year Postimplant - R. Klautz
More informationExtracted from the 2023 EACTS program, focusing on heart valve disease and devices.
All abstracts have been extracted from the EACTS website
Hear Prof. Borger And Dr Bavaria’s Views On The Latest COMMENCE Trial 7-Year Data
Discover
Meet Us On Our Booth
Edwards, Edwards Lifesciences, the stylized E logo, COMMENCE, INSPIRIS, INSPIRIS RESILIA, HemoSphere and RESILIA are trademarks or service marks of Edwards Lifesciences Corporation or its affiliates. All other trademarks or service marks are the property of their respective owners.
©2023 Edwards Lifesciences Corporation. All rights reserved. PP--EU-7023
Edwards Lifesciences ● Route de l'Etraz 70, 1260 Nyon, Switzerland ● edwards.com
Tap here for EACTS annual edition and see our booth's location!
More info on the EACTS annual edition
Learn MoreWhere to find us at EACTS Booth
See Our location
Correct!
Wrong answer!